Differential Diagnosis for Painless, Subacute Monocular Vision Loss

Vascular Etiologies

• The American Heart Association considers central retinal artery occlusion a stroke equivalent, requiring immediate stroke center evaluation 1, 2
• Up to 25% of central retinal artery occlusion patients have concurrent silent brain infarction on MRI, making this a neurological emergency 3, 2
• Branch retinal artery occlusion causes sectoral vision loss and requires urgent stroke evaluation within 24 hours 2
• Risk factors for retinal artery occlusion include cardiovascular disease, hypertension, diabetes, hyperlipidemia, and smoking 3
• The American College of Cardiology recommends immediate empiric high-dose steroids for suspected giant cell arteritis to prevent vision loss in the contralateral eye 2
• Transient monocular vision loss represents a retinal TIA with vision loss lasting seconds to minutes that resolves completely, and stroke risk is highest within the first 7 days after onset 1, 2
• Retinal vein occlusion presents with painless vision loss, often less acute than arterial occlusion, and is associated with hypertension, diabetes, hyperlipidemia, and hypercoagulable states 4

Optic Nerve Etiologies

• Giant cell arteritis must be considered in all patients over 50 years old with sudden vision loss, and is associated with jaw claudication, scalp tenderness, temporal tenderness, headaches, and constitutional symptoms 1, 2
• ESR >60 mm/h has a high likelihood ratio for giant cell arteritis diagnosis 1
• Optic neuritis can be painless in approximately 8% of cases, and is associated with multiple sclerosis, neuromyelitis optica, or other demyelinating conditions 5

Retinal Structural Etiologies

• Ultrasonography is useful for assessing retinal status in cases of retinal detachment or vitreous hemorrhage 3

Critical Diagnostic Approach

• If vascular etiology is confirmed or suspected, immediately refer to certified stroke center ED with note stating "Ocular TIA" or "Ocular Stroke" without performing additional testing 6, 2
• Brain MRI with diffusion-weighted imaging can identify concurrent stroke, present in up to 24% of retinal vascular events 1, 2
• Vascular imaging (CTA or MRA) can assess carotid stenosis, found in up to 70% of symptomatic retinal vascular events 1, 2
• ESR and CRP should be evaluated in patients over 50 years to assess for giant cell arteritis 1, 2

Common Pitfalls to Avoid

• Never assume reperfusion eliminates stroke risk, as stroke risk remains highest in the first 7 days even if vision improves 2
• Never delay giant cell arteritis treatment for biopsy, as empiric steroids should be started immediately in suspected cases 2
• Never underestimate cardiovascular risk, as new significant cardiovascular conditions are discovered in up to 70% of central retinal artery occlusion patients 2
• Never perform extensive ophthalmologic workup before stroke center referral if vascular etiology is suspected 6, 2
• Always check inflammatory markers in patients over 50, regardless of whether classic giant cell arteritis symptoms are present 2

Emergency Evaluation and Management of Sudden Vision Loss

Immediate Referral

• Patients presenting with sudden vision loss should be referred without delay to a certified stroke‑center emergency department or a rapid‑access TIA clinic for urgent neurological evaluation within 24 hours. 7

Clinical History Elements

• The initial history must capture onset characteristics (sudden seconds‑to‑minutes vs. gradual), laterality (monocular vs. binocular), and extent (complete vs. partial loss of vision). 8

Ocular Examination Priorities

• Assessment of extra‑ocular movements is required to detect proptosis or enophthalmos, which may indicate orbital pathology. 8

Trauma‑Related Imaging

• When a history of ocular or facial trauma exists, a non‑contrast thin‑section orbital CT with multiplanar reconstructions should be obtained to identify fractures, foreign bodies, and optic‑canal narrowing. 9
• If a metallic foreign body is suspected, MRI must be avoided and CT used instead. 8

Neuroimaging (within 24 h)

• Brain MRI with diffusion‑weighted imaging is the preferred modality because it detects concurrent cerebral infarction in up to 24 % of retinal vascular events. 7
• If MRI is unavailable, a non‑contrast head CT should be performed. 7

Cervico‑cephalic Vascular Imaging

• Routine non‑invasive imaging of the cervical and cerebral vessels (MRA, CTA, carotid ultrasound, or transcranial Doppler) is recommended; clinically significant carotid stenosis is present in up to 70 % of symptomatic retinal vascular events. 7

Laboratory Evaluation

• Standard blood work should include a complete blood count with platelets, basic chemistry panel, hemoglobin A1c, coagulation studies (PT/PTT), and a fasting lipid panel. 7

Inflammatory Marker Screening (Age > 50 y)

• Erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) are mandatory to screen for giant‑cell arteritis; an ESR > 60 mm/h carries a high likelihood ratio for the disease. 7

Cardiac Assessment

• An electrocardiogram must be obtained immediately on presentation. 7
• If the underlying cause remains unclear after initial imaging, prolonged cardiac monitoring (in‑patient telemetry or outpatient Holter) is advised. 7
• Transthoracic echocardiography is reasonable for all patients; transesophageal echocardiography should be considered when left‑atrial thrombus, patent foramen ovale, or valvular disease is suspected. 7

Admission and Observation

• Patients with confirmed vascular etiology or high‑risk features should be admitted to or observed in a stroke center for comprehensive management. 7

Evidence‑Based Findings on Acute Vision Loss (Cited Sources)

Structural Retinal Causes

• Vitreous hemorrhage can precipitate sudden loss of vision. The citation reports this association based on clinical observations. (Ophthalmology, 2020) 10

• Ocular ultrasonography is valuable for evaluating retinal integrity when media opacity (e.g., dense cataract or vitreous haze) limits direct visualization. The source describes its diagnostic utility in such settings. (Ophthalmology, 2020) 10

Therapeutic Evidence

• No Level‑I (high‑quality randomized) data support any specific acute‑vision‑loss intervention such as digital ocular massage, anterior‑chamber paracentesis, vasodilator therapy, paper‑bag breathing, carbogen, or topical pressure‑lowering agents. The citation explicitly notes the absence of such evidence. (Ophthalmology, 2020) 10

• Recent meta‑analyses indicate that eyes managed with conservative (non‑interventional) therapy have poorer visual outcomes than eyes receiving active control treatments. This finding derives from pooled data of multiple studies, providing moderate‑quality evidence. (Ophthalmology, 2020) 10